Expanding analytical possibilities concerning the detection of stanozolol misuse by means of high resolution/high accuracy mass spectrometric detection of stanozolol glucuronides in human sports drug testing

Drug Testing and Analysis

Volumn 5, Issue 11-12, 2013, Pages 810-818

  Schänzer, Wilhelm ^a   Guddat, Sven ^a   Thomas, Andreas ^a   Opfermann, Georg ^a   Geyer, Hans ^a   Thevis, Mario ^a,b  

^a GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

^b European Monitoring Center for Emerging Doping Agents   (Germany)

Author keywords

16 oxo stanozolol; Anabolic agents; Doping; Long term metabolite; Mass spectrometry; Sport

Indexed keywords

BIOMOLECULES; CONTROLLED DRUG DELIVERY; DIRECT INJECTION; DRUG PRODUCTS; GAS CHROMATOGRAPHY; GLUCOSE; LIQUID CHROMATOGRAPHY; METABOLITES; PHASE SEPARATION; SPORTS;

16-OXO-STANOZOLOL; ANABOLIC AGENTS; DRUG TESTING; GLUCURONIDES; HIGH RESOLUTION; HIGH-ACCURACY; LC-MS-MS; LONG-TERM METABOLITE; OH -; STANOZOLOL;

MASS SPECTROMETRY;

GLUCURONIC ACID; GLUCURONIDE; STANOZOLOL;

ADULT; ARTICLE; CHEMICAL STRUCTURE; CONJUGATE; CONTROLLED STUDY; DOPING; DRUG DETERMINATION; DRUG SCREENING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MASS FRAGMENTOGRAPHY; MEASUREMENT ACCURACY; METABOLITE; MIDDLE AGED; NORMAL HUMAN; PRIORITY JOURNAL; SOLID PHASE EXTRACTION; SPORT; SYNTHESIS; TANDEM MASS SPECTROMETRY; URINALYSIS; VALIDATION PROCESS;

16-OXO-STANOZOLOL; ANABOLIC AGENTS; DOPING; LONG-TERM METABOLITE; MASS SPECTROMETRY; SPORT;

ANABOLIC AGENTS; CHROMATOGRAPHY, LIQUID; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GLUCURONIDES; HUMANS; LIMIT OF DETECTION; MALE; MIDDLE AGED; SOLID PHASE EXTRACTION; STANOZOLOL; SUBSTANCE ABUSE DETECTION; TANDEM MASS SPECTROMETRY;

EID: 84890790026     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.1516     Document Type: Article

References (35)

1. M. Thevis, T. Kuuranne, H. Geyer, W. Schänzer Annual banned-substance review: analytical approaches in human sports drug testing. Drug Test. Anal. 2012, 4, 2.
2. M. Thevis Mass Spectrometry in Sports Drug Testing - Characterization of Prohibited Substances and Doping Control Analytical Assays, John Wiley & Sons Inc., Hoboken, NJ, USA, 2010.
3. R. Masse, C. Ayotte, H. G. Bi, R. Dugal Studies on anabolic steroids. III. Detection and characterization of stanozolol urinary metabolites in humans by gas chromatography-mass spectrometry. J. Chromatogr. 1989, 497, 17.
4. W. Schänzer, G. Opfermann, M. Donike Metabolism of stanozolol: identification and synthesis of urinary metabolites. J. Steroid Biochem. 1990, 36, 153.
5. O. J. Pozo, P. Van Eenoo, K. Deventer, L. Lootens, S. Grimalt, J. V. Sancho, F. Hernandez, P. Meuleman, G. Leroux-Roels, F. T. Delbeke Detection and structural investigation of metabolites of stanozolol in human urine by liquid chromatography tandem mass spectrometry. Steroids 2009, 74, 837.
6. W. Schänzer, P. Delahaut, H. Geyer, M. Machnik, S. Horning Long- term detection and identification of metandienone and stanozolol abuse in athletes by gas chromatography- high- resolution mass spectrometry. J. Chromatogr. B 1996, 687, 93.
7. A. Huenerbein, M. A. Sipoli Marques, S. Pereira Ados, F. R. de Aquino Neto Improvement in steroid screening for doping control with special emphasis on stanozolol. J. Chromatogr. A 2003, 985, 375.
8. A. Leinonen, T. Kuuranne, T. Kotiaho, R. Kostiainen Screening of free 17-alkyl-substituted anabolic steroids in human urine by liquid chromatography-electrospray ionization tandem mass spectrometry. Steroids 2004, 69, 101.
9. S. Guddat, M. Thevis, J. Kapron, A. Thomas, W. Schänzer Application of FAIMS to anabolic androgenic steroids in sport drug testing. Drug Test. Anal. 2009, 1, 545.
10. S. Ahi, A. Beotra, S. Jain Detection of mono-hydroxylated metabolites of stanozolol by HPLC-ESI (+) MS/MS in Indian sports persons. Drug Test. Anal. 2009, 1, 538.
11. M. Thevis, G. Fußhöller, H. Geyer, U. Mareck, G. Sigmund, A. Koch, A. Thomas, W. Schänzer Detection of stanozolol and its major metabolites in human urine by liquid chromatography-tandem mass spectrometry. Chromatographia 2006, 64, 441.
12. M. Thevis, A. A. Makarov, S. Horning, W. Schänzer Mass spectrometry of stanozolol and its analogues using electrospray ionization and collision-induced dissociation with quadrupole-linear ion trap and linear ion trap-orbitrap hybrid mass analyzers. Rapid Commun. Mass Spectrom. 2005, 19, 3369.
13. E. Tudela, K. Deventer, P. Van Eenoo Sensitive detection of 3'-hydroxy-stanozolol glucuronide by liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 2013, 1292, 195.
14. World Anti-Doping Agency. 2013, Prohibited List. Available at: http://www.wada-ama.org/en/World-Anti-Doping-Program/Sports-and-Anti-Doping-Organizations/International-Standards/Prohibited-List/ [7 January 2013].
15. W. Koenigs, E. Knorr Ueber einige Derivate des Traubenzuckers und der Galactose. Chem. Ber. 1901, 34, 957.
16. W. F. Goebel, F. H. Babers Derivatives of glucuronic acid. J. Biol. Chem. 1935, 110, 707.
17. J. S. Elce, J. G. D. Carpenter, A. E. Kellie The synthesis of oestrogen monoglucuronides. J. Chem. Soc. 1967, 542. DOI:10.1039/J39670000542.
18. M. Thevis, G. Opfermann, H. Schmickler, W. Schänzer Mass spectrometry of steroid glucuronide conjugates. I. Electron impact fragmentation of 5alpha-/5beta-androstan-3alpha-ol-17-one glucuronides, 5alpha-estran-3alpha-ol-17-one glucuronide and deuterium-labelled analogues. J. Mass Spectrom. 2001, 36, 159.
19. M. Donike, J. Zimmermann, K. R. Bärwald, W. Schänzer, V. Christ, K. Klostermann, et al. Routinebestimmung von Anabolika in Harn. Dtsch. Z. Sportmed. 1984, 35, 14.
20. V. Graef, E. Furuya, O. Nishikaze Hydrolysis of steroid glucuronides with beta-glucuronidase preparations from bovine liver, Helix pomatia, and E. coli. Clin. Chem. 1977, 23, 532.
21. H. Geyer, W. Schänzer, U. Mareck-Engelke, E. Nolteernsting, G. Opfermann in Recent Advances in Doping Analysis, (Eds: W. Schänzer, H. Geyer, A. Gotzmann, and U. Mareck-Engelke ). Sport und Buch Strauss: Cologne, Vol. 5, 1997, pp. 99.
22. M. Thevis, G. Opfermann, H. Schmickler, W. Schanzer Mass spectrometry of steroid glucuronide conjugates. II - Electron impact fragmentation of 3-keto-4-en- and 3-keto-5alpha-steroid-17-O-beta glucuronides and 5alpha-steroid-3alpha, 17beta-diol 3- and 17-glucuronides. J. Mass Spectrom. 2001, 36, 998.
23. L. Hintikka, T. Kuuranne, O. Aitio, M. Thevis, W. Schanzer, R. Kostiainen Enzyme-assisted synthesis and structure characterization of glucuronide conjugates of eleven anabolic steroid metabolites. Steroids 2008, 73, 257.
24. W. Schänzer, M. Donike Metabolism of anabolic steroids in man: synthesis and use of reference substances for identification of anabolic steroid metabolites. Anal. Chim. Acta 1993, 275, 23.
25. A. R. McKinney, C. J. Suann, A. J. Dunstan, S. L. Mulley, D. D. Ridley, A. M. Stenhouse Detection of stanozolol and its metabolites in equine urine by liquid chromatography-electrospray ionization ion trap mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2004, 811, 75.
26. W. Schänzer, H. Geyer, G. Fusshöller, N. Halatcheva, M. Kohler, M. K. Parr, S. Guddat, A. Thomas, M. Thevis Mass spectrometric identification and characterization of a new long-term metabolite of metandienone in human urine. Rapid Comm. Mass Spectrom. 2006, 20, 2252.
27. M. K. Parr, G. Fußhöller, M. Gütschow, C. Hess, W. Schänzer in Recent Advances in Doping Analysis, (Eds: W. Schänzer, H. Geyer, A. Gotzmann and U. Mareck ). Sport und Buch Strauß: Cologne, Vol. 18, 2010, pp. 64.
28. T. Sobolevsky, G. Rodchenkov Detection and mass spectrometric characterization of novel long-term dehydrochloromethyltestosterone metabolites in human urine. J. Steroid Biochem. Mol. Biol. 2012, 128, 121.
29. T. Sobolevsky, G. Rodchenkov Mass spectrometric description of novel oxymetholone and desoxymethyltestosterone metabolites identified in human urine and their importance for doping control. Drug Test. Anal. 2012, 4, 682.
30. World Anti-Doping Agency. 2009, Insternational Standard for Laboratories. Available at: http://www.wada-ama.org/rtecontent/document/International_Standard_for_Laboratories_v6_0_January_2009.pdf [24 November 2008].
31. M. Thevis, A. Thomas, W. Schänzer Current role of LC-MS(/MS) in doping control. Anal. Bioanal. Chem. 2011, 401, 405.
32. A. Musenga, D. A. Cowan Use of ultra-high pressure liquid chromatography coupled to high resolution mass spectrometry for fast screening in high throughput doping control. J. Chromatogr. A 2013, 1288, 82.
33. A. J. Giron, K. Deventer, K. Roels, P. Van Eenoo Development and validation of an open screening method for diuretics, stimulants and selected compounds in human urine by UHPLC-HRMS for doping control. Anal. Chim. Acta 2012, 721, 137.
34. M. Kolmonen, A. Leinonen, A. Pelander, I. Ojanpera A general screening method for doping agents in human urine by solid phase extraction and liquid chromatography/time-of-flight mass spectrometry. Anal. Chim. Acta 2007, 585, 94.
35. C. G. Georgakopoulos, A. Vonaparti, M. Stamou, P. Kiousi, E. Lyris, Y. S. Angelis, G. Tsoupras, B. Wuest, M. W. Nielen, I. Panderi, M. Koupparis Preventive doping control analysis: liquid and gas chromatography time-of-flight mass spectrometry for detection of designer steroids. Rapid Commun. Mass Spectrom. 2007, 21, 2439.